Experts
Supporters
About Mirrors of Medicine
Disease Area
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
my dashboard
Join
Login
EN
EN
FR
DE
IT
ES
RU
UK
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
Method
Experts
Supporters
Principles
About Mirrors of Medicine
Contact
Prostate cancer
mCRPC: novel and emerging agents
Editor in chief
Experts & associates
Background & relevance
Last update: 07-04-2023
View the PinPoint cases (
) and get feedback
CRPC following AR-targeted agent and chemotherapy
CRPC and family history of PCa
Somatic BRCA2 mutation (1)
Somatic BRCA2 mutation (2)
Somatic ATM mutation
MMR deficiency
CRPC following AR-targeted agent and chemotherapy (2)
CRPC following AR-targeted agent and chemotherapy (3)
Tumour with PTEN loss
